CheezhengTTM(SZ:002287) Zheng Quan Zhi Xing·2025-08-01 16:13Core Viewpoint - The company, Tibet Qizheng Tibetan Medicine Co., Ltd., has announced the potential triggering of conditional redemption for its convertible bonds, "Qizheng Convertible Bonds," based on stock price performance exceeding 130% of the conversion price [1][7]. Group 1: Convertible Bond Basic Information - The company has issued a total of 8 million convertible bonds with a face value of 100 RMB each, amounting to a total issuance of 800 million RMB [2]. - The bonds are listed on the Shenzhen Stock Exchange and have been trading since October 27, 2020 [2]. - The conversion period for the bonds is from March 29, 2021, to September 21, 2026 [2]. Group 2: Conversion Price Adjustments - The conversion price has undergone several adjustments since issuance, with the latest adjustment on July 10, 2025, bringing it to 19.01 RMB per share [6][9]. - The conversion price was previously adjusted downwards multiple times, reflecting the company's strategic decisions based on market conditions [3][5][6]. Group 3: Conditional Redemption Terms - The company has outlined specific conditions under which it can redeem the convertible bonds, including if the stock price remains above 130% of the conversion price for at least 15 out of 30 consecutive trading days [7][8]. - The company also has the right to redeem the bonds if the remaining balance of unconverted bonds falls below 30 million RMB [7]. Group 4: Recent Stock Performance - As of July 21 to August 1, 2025, the company's stock has closed above 24.713 RMB per share for 9 trading days, indicating a potential trigger for the redemption clause [1][7].